Eton Pharmaceuticals (ETON) Accounts Payables (2017 - 2025)

Eton Pharmaceuticals has disclosed Accounts Payables across 9 years of filings, most recently posting $11.0 million for Q4 2025.

• Accounts Payables for Q4 2025 came in at $11.0 million, up 163.4% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.0 million (up 163.4% YoY), and the FY2025 annual result was $11.0 million, up 163.4% from the prior year.
• Accounts Payables came in at $11.0 million for Q4 2025 at Eton Pharmaceuticals, down from $14.3 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $14.3 million in Q3 2025 to a low of $1.1 million in Q3 2022.
• The 5-year median for Accounts Payables is $2.1 million (2022), against an average of $3.8 million.
• Across the five-year window, Accounts Payables plunged 67.8% in 2022 and jumped 469.25% in 2025, its largest moves.
• Eton Pharmaceuticals' Accounts Payables stood at $1.8 million in 2021, then retreated by 0.45% to $1.8 million in 2022, then gained by 4.64% to $1.8 million in 2023, then soared by 125.49% to $4.2 million in 2024, then soared by 163.4% to $11.0 million in 2025.
• The last three Accounts Payables figures came in at $11.0 million (Q4 2025), $14.3 million (Q3 2025), and $12.1 million (Q2 2025), per Business Quant data.